UMT-17783-65070
4 vaccinations
6 coded responses
51 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 229 / VA
- Registered
- 2021-01-20
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-20
Registered in v-safe
-
2021-01-20
Dose 1 — Moderna
- 2021-01-20
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-02-03
- 2021-02-10
-
2021-02-17
Dose 2 — Moderna
-
2021-02-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling, Itching · NoneAdult check-in
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-03-03
- 2021-03-10
- 2021-03-17
- 2021-03-26
- 2021-04-02
- 2021-05-19
-
2021-08-18
Survey response — 6 months, dose 2MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Head coldMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-26
Dose 3 — Moderna
-
2021-10-27
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Be unable to do your normal daily activitiesFree text: Severely swollen lymph nodes in arm pitMedDRA releases: 2024-11 · check-in free text available
-
2021-10-28
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: Swelling · Diarrhea · Be unable to do your normal daily activitiesFree text: Swollen lymph nodes in arm pitMedDRA releases: 2024-11 · check-in free text available
-
2021-10-29
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: GoodFree text: Slightly swollen lymph nodes in arm pitMedDRA releases: 2024-11 · check-in free text available
- 2021-10-30
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-09
- 2021-11-16
- 2021-11-23
- 2021-11-30
- 2021-12-07
- 2022-01-25
- 2022-04-28
-
2022-10-11
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-11
- 2022-10-13
- 2022-10-14
- 2022-10-15
- 2022-10-16
- 2022-10-17
- 2022-10-18
- 2022-10-25
- 2022-11-01
- 2022-11-08
- 2022-11-15
- 2022-11-22
-
2023-01-10
Survey response — 3 months, dose 4MedDRA: Hypoaesthesia, Malaise, Office visit, Vertigo — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-10
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-01-11
-
2023-04-11
Survey response — 6 months, dose 4MedDRA: Office visit, Pregnancy — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11
-
2023-04-11
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2023-04-12
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-04-12
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-20 | Moderna | |
| 2 | 2021-02-17 | Moderna | |
| 3 | 2021-10-26 | Moderna | No |
| 4 | 2022-10-11 | Pfizer-BioNTech | Flu |
Call center
2 call center cases
2 successful
Free text
Release 9 — 6 months, dose 2
Symptoms: Head cold
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Severely swollen lymph nodes in arm pit
Systemic reaction (other): Swollen lymph nodes in arm pit
Systemic reaction (other): Slightly swollen lymph nodes in arm pit
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Hypoaesthesia | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Vertigo | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release